Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Ralph R. Weichselbaum and Harvey M. Golomb.

 
Connection Strength
 
 
 
0.156
 
  1. Hartsell WF, Farah R, Murthy A, Golomb H, Weichselbaum R. Is pelvic irradiation necessary in stage III1A Hodgkin's disease? Int J Radiat Oncol Biol Phys. 1990 Sep; 19(3):715-9.
    View in: PubMed
    Score: 0.029
  2. Hallahan DE, Farah R, Vokes EE, Bitran JD, Ultmann JE, Golomb HM, Weichselbaum RR. The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):767-71.
    View in: PubMed
    Score: 0.027
  3. Farah R, Golomb HM, Hallahan DE, Desser RK, Griem ML, Blough R, Ultmann JE, Weichselbaum RR. Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):761-6.
    View in: PubMed
    Score: 0.027
  4. Vokes EE, Bitran JD, Hoffman PC, Ferguson MK, Weichselbaum RR, Golomb HM. Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study. Chest. 1989 Jul; 96(1):110-3.
    View in: PubMed
    Score: 0.026
  5. Farah R, Ultmann J, Griem M, Golomb H, Kalokhe U, Desser R, Blough R, Weichselbaum R. Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease. J Clin Oncol. 1988 Jun; 6(6):1047-52.
    View in: PubMed
    Score: 0.025
  6. Jacobs RH, Awan A, Bitran JD, Hoffman PC, Little AG, Ferguson MK, Weichselbaum R, Golomb HM. Prophylactic cranial irradiation in adenocarcinoma of the lung. A possible role. Cancer. 1987 Jun 15; 59(12):2016-9.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.